Navigation Links
GenVec Reports Third Quarter 2010 Financial Results
Date:11/8/2010

GAITHERSBURG, Md., Nov. 8, 2010 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC) today announced its financial results for the third quarter ended September 30, 2010.  

GenVec reported a net loss of $2.4 million ($0.02 per share) for the three months ended September 30, 2010 compared to a net loss of $3.6 million ($0.04 per share) in the comparable quarter of 2009. For the nine months ended September 30, 2010, GenVec's net loss was $11.3 million ($0.09 per share) compared to a net loss of $14.1 million ($0.15 per share) for the nine months ended September 30, 2009.  

Revenues for the three-month and nine-month periods ended September 30, 2010 were $5.2 million and $11.3 million, respectively, representing increases of 76 percent and 7 percent as compared to $2.9 million and $10.5 million in the comparable prior year periods. The increase for the three and nine-month periods ended September 30, 2010 is primarily due to increased revenue associated with our hearing loss and balance disorder program and collaboration with Novartis that began in January 2010.  During the three and nine-month periods ended September 30, 2010 our revenues for this program increased $3.1 million and $4.5 million, respectively.  Partially offsetting the increase in revenue associated with our hearing loss and balance disorder program is lower revenue under both the foot and mouth disease (FMD) and HIV programs, a result of the decreased work scope and effort in 2010 as compared to the 2009 periods.  Revenue for the three and nine-month periods ended September 30, 2010 associated with our FMD program decreased $267,000 and $2.4 million, respectively, as compared to the prior year periods.  Revenue for the three and nine-month periods ended September 30, 2010 associated with our HIV program decreased $0.7 million and $1.6 million, respectively, as compared to t
'/>"/>

SOURCE GenVec, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GenVec Receives Second-Year Funding From SAIC for HIV and Influenza Vaccine Development
2. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
3. GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting
4. Medtronic, Stryker, and BrainLAB Covered in New Surgical Navigation Market Research Reports Released by Millennium Research Group
5. ADVENTRX Reports Third Quarter Financial Results
6. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2011 Financial Results
7. Medivation Reports Third Quarter 2010 Financial Results and Provides Corporate Update
8. Allied Healthcare Products Reports Narrow Loss for Quarter But Improves Year-Over-Year Performance
9. Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results
10. NOVAVAX Reports Third Quarter 2010 Financial Results
11. Savient Pharmaceuticals Announces Expected Availability of KRYSTEXXA™ for Prescription and Reports Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 24, 2014 Research and Markets  has ... Current Trends, Opportunities - Global Forecast to 2019" ... report, the global dental equipment market is categorized on ... and equipment market is expected to register the highest ... forecast period (2014 to 2019). This high growth is ...
(Date:10/25/2014)... LOVELAND, Colo. , Oct. 24, 2014  Heska ... Webcast: What:Heska Corporation Invites You to Join Its Third ... 29, 2014 @ 9:00 a.m. (MDT) / 11:00 a.m. ... 2014 Earnings Call link on the front page of ... to the web at the address above.  Alternatively, you ...
(Date:10/25/2014)...  In 2008, two of Dr. Gurney,s employees reported ... substances, on a regular basis, that were not used ... was practicing "all the time" while under the influence. ... said that Dr. Gurney was prone to "making mistakes ... Dr. Gurney,s behavior became increasingly erratic and unfocused, and ...
Breaking Medicine Technology:Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Webcast Alert: Heska Announces Third Quarter 2014 Earnings Conference Call Webcast 2Doctors That Harm: The Real Stories Insurance Companies Against Prop 46 Don't Want You To Know, Part 8 of Consumer Watchdog Campaign Series 2Doctors That Harm: The Real Stories Insurance Companies Against Prop 46 Don't Want You To Know, Part 8 of Consumer Watchdog Campaign Series 3
... Plexus Biomedical Inc. has been granted a new ... to market the first device clinically shown to help ... vaginal delivery are a frequent complication of childbirth and ... U.S. every year. The patented Hem-Avert® Perianal ...
... 2011 GeoVax Labs, Inc. (OTC Bulletin Board: ... Phase 1 clinical trial testing of its HIV/AIDS vaccine products. ... DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like ... The Journal of Infectious Diseases . A PDF ...
Cached Medicine Technology:Plexus Biomedical Inc. Gains FDA Approval of the First Medical Device to Help Prevent External Hemorrhoids During Vaginal Childbirth 2GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases 2GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases 3GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases 4
(Date:10/25/2014)... Oct. 25, 2014 (HealthDay News) -- Arriving home safe and ... To that end, be sure that costumes and goody ... Dr. Sampson Davis, an emergency medicine doctor at Meadowlands Hospital ... carry a flashlight, and costumes should be flame-resistant, Davis said. ... plan to use makeup, test it on a small area ...
(Date:10/25/2014)... 25, 2014 TASC (Total Administrative ... other benefits account management services, announces the release ... save on taxes, reduce administrative workload, and lessen ... savings and the efficient handling of complex, time-sensitive, ... that best meets their goals and objectives. The ...
(Date:10/25/2014)... Oshkosh, Wisconsin (PRWEB) October 25, 2014 ... looking for a great selection at affordable prices. Bob ... Civic Center Huntington Center and Nationwide Arena are going ... quickly. , Click Here to browse the ... Bullet Band at QueenBeeTickets.com. , The famous singer is ...
(Date:10/25/2014)... Raleigh, NC (PRWEB) October 25, 2014 ... patient who continued to receive pemetrexed (Alimta), after his ... to read the full story , just posted on ... study from Uji Tokushukai Medical Center in Japan suggests ... for mesothelioma patients who cannot tolerate higher ...
(Date:10/25/2014)... Steven Reinberg HealthDay Reporter ... that causes common cold sores -- herpes simplex -- might ... researchers suggest. In fact, being a carrier of certain ... disease, the researchers found. "The identification of a ... is a breakthrough," said lead researcher Dr. Hugo Lovheim, an ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:TASC’s New Suites Offer Tax Savings and Protection 2Health News:QueenBeeTickets.com Features Bob Seger & The Silver Bullet Band Tickets for Charleston Civic Center, Huntington Center, and Nationwide Arena at Reduced Prices 2Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3
... Institutet in Sweden shows, that a specific inflammatory factor ... valve disease aortic stenosis. The results suggest that anti-inflammatory ... stenosis is the most common heart valve disease, which ... the aortic valve. This is typically seen in the ...
... incidence and mortality associated with hepatocellular carcinoma (HCC) ... (HCV) infection plays an important role in the ... host factors, such as sex, alcohol consumption, smoking, ... for HCC. Meanwhile, it has been reported that ...
... diabetes is dramatically increasing throughout the world. Insulin resistance ... most often precedes the onset of hyperglycemia and predicts ... the agonists of the peroxisome proliferators-activated receptor γ, are ... liver, adipose tissue, and skeletal muscle, thus improving glycaemic ...
... , TUESDAY, March 15 (HealthDay News) -- Guidelines ... to be updated, say researchers who reviewed 69 studies ... The review produced new reference ranges that differ widely ... of Oxford University in the United Kingdom, and colleagues. ...
... industry is booming in China as a rapid increase ... nationwide shift from traditional family care to institutional care, ... The study, led by Zhanlian Feng, assistant professor of ... of the American Geriatrics Society , is the first ...
... MONDAY, March 14 (HealthDay News) -- Doctors today are more ... 10 years ago, but they still fall short on counseling ... study finds. Researchers at the U.S. Centers for Disease ... system met arthritis-management goals set by the federal government in ...
Cached Medicine News:Health News:Inflammation behind heart valve disease 2Health News:Updates Urged for Kids' Heart, Breathing Rate Guidelines 2Health News:Nursing home boom in China has little government involvement 2Health News:Nursing home boom in China has little government involvement 3Health News:Doctors Need to Improve Guidance on Arthritis: Study 2Health News:Doctors Need to Improve Guidance on Arthritis: Study 3
... Mini Step™ device components are supplied sterile. , ... System is supplied sterile in 2/3, 5, 7/8, ... configurations and combinations. They are used in conjunction ... the Step™ radially Expandable Sleeve. The 5, 7/8, ...
... contains an internal seal to prevent gas leakage ... of pneumoperitoneum. The 5 mm PLUS system includes ... mm - 12 mm as appropriate and is ... of the trocar to allow insertion of smaller ...
VERSAPORT™ Plus RT Single Use Obturators for use with VERSAPORT™ RT Reusable Cannulae....
... SPRING-GRIP™ single use nonconductive anchoring devices are ... mm and 12 mm sizes for use ... mm, 5 mm-10 mm, 5 mm-11 mm, ... sizes for use with the VERSAPORT™, SURGISPIKE™, ...
Medicine Products: